Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology firm specializing in biological products trading at $1.93 per share, announced the upcoming departure of Timothy Moore, an executive officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback